94 related articles for article (PubMed ID: 543875)
1. Synthesis and anti-inflammatory properties of budesonide, a new non-halogenated glucocorticoid with high local activity.
Thalén A; Brattsand R
Arzneimittelforschung; 1979; 29(11):1687-90. PubMed ID: 543875
[TBL] [Abstract][Full Text] [Related]
2. Correlation between chemical structure, receptor binding, and biological activity of some novel, highly active, 16 alpha, 17 alpha-acetal-substituted glucocorticoids.
Dahlberg E; Thalén A; Brattsand R; Gustafsson JA; Johansson U; Roempke K; Saartok T
Mol Pharmacol; 1984 Jan; 25(1):70-8. PubMed ID: 6708937
[TBL] [Abstract][Full Text] [Related]
3. Development of glucocorticosteroids with enhanced ratio between topical and systemic effects.
Thalén A; Brattsand R; Andersson PH
Acta Derm Venereol Suppl (Stockh); 1989; 151():11-9; discussion 47-52. PubMed ID: 2624062
[TBL] [Abstract][Full Text] [Related]
4. Budesonide: a new corticosteroid in bronchial asthma.
Ellul-Micallef R; Hansson E; Johansson SA
Eur J Respir Dis; 1980 Jun; 61(3):167-73. PubMed ID: 7002575
[TBL] [Abstract][Full Text] [Related]
5. Metabolic acetal splitting of budesonide. A novel inactivation pathway for topical glucocorticoids.
Edsbäcker S; Andersson P; Lindberg C; Ryrfeldt A; Thalén A
Drug Metab Dispos; 1987; 15(3):412-7. PubMed ID: 2886320
[TBL] [Abstract][Full Text] [Related]
6. Influence of 16 alpha, 17 alpha-acetal substitution and steroid nucleus fluorination on the topical to systemic activity ratio of glucocorticoids.
Brattsand R; Thalén A; Roempke K; Källström L; Gruvstad E
J Steroid Biochem; 1982 Jun; 16(6):779-86. PubMed ID: 7109581
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonide.
Stoeck M; Riedel R; Hochhaus G; Häfner D; Masso JM; Schmidt B; Hatzelmann A; Marx D; Bundschuh DS
J Pharmacol Exp Ther; 2004 Apr; 309(1):249-58. PubMed ID: 14718604
[TBL] [Abstract][Full Text] [Related]
8. Derivatives of 2-bromo-6beta-fluoropregna-1,4-diene-3,20-dione and their antiinflammatory activity.
Toscano L; Barlotti L; Fioriello G; Grisanti G; Bossoni G; Biraschi LM; Riva M
Arzneimittelforschung; 1977; 27(9):1628-33. PubMed ID: 579127
[TBL] [Abstract][Full Text] [Related]
9. A highly topically active corticosteroid. Preliminary report.
Mizushima Y; Miyake H; Fujiwara K; Ono N; Takikawa K
Arzneimittelforschung; 1980; 30(2):274-5. PubMed ID: 7378106
[TBL] [Abstract][Full Text] [Related]
10. 3-Chloro-1,3,5-pregnatriene derivatives with glucocorticoid activity.
Arányi P; Náray A; Ninh NV; Fekete G; Tóth J; Horváth I
Steroids; 1983 Oct; 42(4):409-15. PubMed ID: 6149638
[TBL] [Abstract][Full Text] [Related]
11. A novel class of local antiinflammatory steroids. 1st communication: analogues of methyl 11 beta,17 alpha,21-trihydroxy-3,20-dioxo-pregna-1,4-diene-16 alpha-carboxylate.
Taraporewala IB; Kim HP; Heiman AS; Lee HJ
Arzneimittelforschung; 1989 Jan; 39(1):21-5. PubMed ID: 2719741
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological properties of novel glucocorticoid androstene C-17 furoate esters.
Sandham DA; Barker L; Beattie D; Beer D; Bidlake L; Bentley D; Butler KD; Craig S; Farr D; Ffoulkes-Jones C; Fozard JR; Haberthuer S; Howes C; Hynx D; Jeffers S; Keller TH; Kirkham PA; Maas JC; Mazzoni L; Nicholls A; Pilgrim GE; Schaebulin E; Spooner GM; Stringer R; Tranter P; Turner KL; Tweed MF; Walker C; Watson SJ; Cuenoud BM
Bioorg Med Chem; 2004 Oct; 12(19):5213-24. PubMed ID: 15351404
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory properties of tixocortol 17-butyrate,21-propionate (JO 1222), a novel, locally acting corticosteroid.
Moodley I; Grouhel A; Lelièvre V; Junien JL
J Lipid Mediat; 1991; 3(1):51-70. PubMed ID: 1768840
[TBL] [Abstract][Full Text] [Related]
14. The effect of budesonide and triamcinolone acetonide on hepatic microsomal testosterone metabolism in the rat.
Edwards RJ; Freeling AB; Watson D; Davies DS
Biochem Pharmacol; 1992 Jan; 43(2):271-82. PubMed ID: 1739415
[TBL] [Abstract][Full Text] [Related]
15. Antiinflammatory activity and other pharmacological properties of 11 beta, 21-dihydroxy-2'-methyl-5' beta H-pregna-1,4 dieno[17,16-d] oxazole 3,20-dione-21-acetate (Deflazacort).
Schiatti P; Selva D; Barone D; Restelli A; Glässer A
Arzneimittelforschung; 1980; 30(9):1543-9. PubMed ID: 7193023
[TBL] [Abstract][Full Text] [Related]
16. Metabolic pathways of the topical glucocorticoid budesonide in man.
Edsbäcker S; Jönsson S; Lindberg C; Ryrfeldt A; Thalén A
Drug Metab Dispos; 1983; 11(6):590-6. PubMed ID: 6140145
[TBL] [Abstract][Full Text] [Related]
17. 6 alpha-Fluoro- and 6 alpha,9 alpha-difluoro-11 beta,21-dihydroxy-16 alpha,17 alpha-propylmethylenedioxypregn-4-ene-3,20-dione: synthesis and evaluation of activity and kinetics of their C-22 epimers.
Thalén BA; Axelsson BI; Andersson PH; Brattsand RL; Nylander B; Wickström LI
Steroids; 1998 Jan; 63(1):37-43. PubMed ID: 9437793
[TBL] [Abstract][Full Text] [Related]
18. A novel class of local antiinflammatory steroids. 2nd communication: pharmacological studies of methyl 11 beta,17 alpha,21- trihydroxy-3,20-dioxo-pregna-1,4-diene-16 alpha-carboxylate and methyl 11 beta,21-dihydroxy-3,20-dioxo-pregna-1,4-diene-16 alpha-carboxylate.
Heiman AS; Kim HP; Taraporewala IB; Lee HJ
Arzneimittelforschung; 1989 Feb; 39(2):262-7. PubMed ID: 2567170
[TBL] [Abstract][Full Text] [Related]
19. Biotransformation rate (in vitro) and systemic potency (in vivo) of the topical glucocorticoid budesonide in male and female rats.
Andersson P; Brattsand R; Edsbäcker S; Källström L; Ryrfeldt A
J Steroid Biochem; 1982 Dec; 17(6):703-6. PubMed ID: 7176660
[TBL] [Abstract][Full Text] [Related]
20. Antiinflammatory activity and thymolytic effect of a new corticosteroid ester (I.S.F. 2073) by topical application.
Banfi S; Cornelli U; Carpi C
Curr Ther Res Clin Exp; 1976 Jan; 19(1):126-32. PubMed ID: 812657
[No Abstract] [Full Text] [Related]
[Next] [New Search]
